These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35884998)

  • 41. COVID-19 Salivary Protein Profile: Unravelling Molecular Aspects of SARS-CoV-2 Infection.
    Esteves E; Mendes VM; Manadas B; Lopes R; Bernardino L; Correia MJ; Barros M; Esteves AC; Rosa N
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes.
    Keur N; Saridaki M; Ricaño-Ponce I; Netea MG; Giamarellos-Bourboulis EJ; Kumar V
    Respir Med; 2023 Oct; 217():107331. PubMed ID: 37364721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet proteome reveals features of cell death, antiviral response and viral replication in covid-19.
    Trugilho MRO; Azevedo-Quintanilha IG; Gesto JSM; Moraes ECS; Mandacaru SC; Campos MM; Oliveira DM; Dias SSG; Bastos VA; Santos MDM; Carvalho PC; Valente RH; Hottz ED; Bozza FA; Souza TML; Perales J; Bozza PT
    Cell Death Discov; 2022 Jul; 8(1):324. PubMed ID: 35842415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients.
    van de Sand L; Braß P; Gregorius J; Pattberg K; Engler A; Dittmer U; Taube C; Brock S; Berger MM; Brenner T; Witzke O; Krawczyk A
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma Proteins Associated with COVID-19 Severity in Puerto Rico.
    Rosario-Rodríguez LJ; Cantres-Rosario YM; Carrasquillo-Carrión K; Rosa-Díaz A; Rodríguez-De Jesús AE; Rivera-Nieves V; Tosado-Rodríguez EL; Méndez LB; Roche-Lima A; Bertrán J; Meléndez LM
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complex changes in serum protein levels in COVID-19 convalescents.
    Pushalkar S; Wu S; Maity S; Pressler M; Rendleman J; Vitrinel B; Jeffery L; Abdelhadi R; Chen M; Ross T; Carlock M; Choi H; Vogel C
    Sci Rep; 2024 Feb; 14(1):4479. PubMed ID: 38396092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SERPINA3: Stimulator or Inhibitor of Pathological Changes.
    de Mezer M; Rogaliński J; Przewoźny S; Chojnicki M; Niepolski L; Sobieska M; Przystańska A
    Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The human host response to monkeypox infection: a proteomic case series study.
    Wang Z; Tober-Lau P; Farztdinov V; Lemke O; Schwecke T; Steinbrecher S; Muenzner J; Kriedemann H; Sander LE; Hartl J; Mülleder M; Ralser M; Kurth F
    EMBO Mol Med; 2022 Nov; 14(11):e16643. PubMed ID: 36169042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlates with Vaccine Protective Capacity and COVID-19 Disease Symptoms Identified by Serum Proteomics in Vaccinated Individuals.
    Villar M; Urra JM; Artigas-Jerónimo S; Mazuecos L; Contreras M; Vaz-Rodrigues R; Rodríguez-Del-Río FJ; Gortázar C; de la Fuente J
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity Assessment.
    Nuñez E; Orera I; Carmona-Rodríguez L; Paño JR; Vázquez J; Corrales FJ
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19.
    Zoodsma M; de Nooijer AH; Grondman I; Gupta MK; Bonifacius A; Koeken VACM; Kooistra E; Kilic G; Bulut O; Gödecke N; Janssen N; Kox M; Domínguez-Andrés J; van Gammeren AJ; Ermens AAM; van der Ven AJAM; Pickkers P; Blasczyk R; Behrens GMN; van de Veerdonk FL; Joosten LAB; Xu CJ; Eiz-Vesper B; Netea MG; Li Y
    Front Immunol; 2022; 13():1027122. PubMed ID: 36405747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response.
    Bock JO; Ortea I
    Aging (Albany NY); 2020 Jun; 12(12):11277-11286. PubMed ID: 32575076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo.
    Beltrán-Camacho L; Eslava-Alcón S; Rojas-Torres M; Sánchez-Morillo D; Martinez-Nicolás MP; Martín-Bermejo V; de la Torre IG; Berrocoso E; Moreno JA; Moreno-Luna R; Durán-Ruiz MC
    Mol Med; 2022 Apr; 28(1):40. PubMed ID: 35397534
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.